Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention suggests that different types of cancer fear...
Big progress was made in 2014, in the form of FDA approvals for new immunotherapies, targeted therapies, and a...
Hugh Gannon, PhD, a recipient of the 2013 Anna D. Barker Fellowship in Basic Cancer Research, is studying p53's...
With the late-breaking and clinical trial-placeholder abstract deadlines a week away, we thought it was a good time to...
A major question that researchers are trying to answer is: What links obesity with cancer development and adverse survival?
Guest Post by Adam Marcus, PhD Winship Cancer Institute of Emory University
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
A new documentary, produced by Ken Burns and based on the Pulitzer Prize-winning book The Emperor of All Maladies:...
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...